Jill Herschleb

Title: Jill Herschleb: Innovator in Nucleic Acid Technologies

Introduction

Jill Herschleb is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid technologies. With a total of 3 patents, her work has advanced the understanding and application of fixed biological samples in various assays.

Latest Patents

Herschleb's latest patents include innovative methods for generating barcoded nucleic acid molecules using fixed cells. The first patent provides compositions and methods for utilizing fixed biological samples in partition-based assays. This disclosure includes a composition comprising a fixed biological sample and an un-fixing agent contained in a partition, such as a discrete droplet. In some embodiments, the un-fixing agent compounds are capable of catalytically cleaving crosslinks in fixed biological samples, particularly crosslinked nucleic acids like RNA. The second patent also focuses on compositions and methods for using fixed biological samples, reiterating the importance of these advancements in partition-based assays.

Career Highlights

Jill Herschleb is currently employed at 10x Genomics, Inc., where she continues to push the boundaries of innovation in her field. Her work has been instrumental in developing new methodologies that enhance the efficiency and accuracy of biological assays.

Collaborations

Throughout her career, Herschleb has collaborated with notable colleagues, including Joshua Delaney and Shalini Gohil. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Jill Herschleb's contributions to the field of biotechnology, particularly through her patents and work at 10x Genomics, Inc., highlight her role as a leading innovator. Her advancements in nucleic acid technologies are paving the way for future research and applications in the life sciences.